Leap Wireless: Vulture venture Apr 7, 2008
Leap investor David Cohen, of Iridian Asset Management, is involved in a very public attempt to oust the chief executive of ICN Pharmaceuticals. Iridian owns nearly 5 percent of Leap. (San Diego Union-Tribune)
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting Dec 6, 2007
Mr. Bailey served as Executive Vice President and Chief Financial Officer of Valeant Pharmaceuticals International (formerly ICN Pharmaceuticals, Inc.) from December 2002 to May 2007 and as Executive Vice President, Strategy and Technology, of PacifiCare Health Systems, Inc. from July 2000 to December 2002. -- Jay B. Hunt. (PR Newswire)
Brown leans on backers for help with legal bills from failed GOP suit May 7, 2007
-- Serbian American businessman Milan Panic, former chairman and CEO of ICN Pharmaceuticals and self-described "entrepreneur, statesman, global businessman, humanist, citizen, scientist, philanthropist (and) charismatic leader," was good for $10,000. -- Plus the usual suspects: the prison guards union ($12,500), the carpenters union ($10,000), the California Dental Political Action Committee ($7,500), the Association for Los Angeles Deputy Sheriffs ($3,000), and the Auburn Indian Community,... (San Francisco Chronicle)
